Centre hospitalier de Dunkerque

Dunkirk 59385

0 studies enrolling now · 6 studies all time

What they study most

Cystic Fibrosis, Indolent Non-Hodgkin's Lymphomas, Refractory Follicular Lymphoma, Relapsed Follicular Lymphoma, Relapsed and/or Refractory Multiple Myeloma, Relapsed/Refractory Follicular Non-Hodgkin Lymphoma

Studies at this site

• A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma — Completed
• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma — Stopped early
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early